Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Kazmi

Showing results (131-140 of 156) with videos related to

Pageof 16
Sort By:
The Oncologist|October 24, 2013
Impact of molecular alterations and targeted therapy in appendiceal adenocarcinomasKanwal P S Raghav, Aditya V Shetty, Syed M A Kazmi, et al.
Plos Biology|June 30, 2021
An oxytocin/vasopressin-related neuropeptide modulates social foraging behavior in the clonal raider antIngrid Fetter-Pruneda, Taylor Hart, Yuko Ulrich, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|February 14, 2023
Biological basis and proposed mechanism of action of CSL112 (apolipoprotein A-I [human]) for prevention of major adverse cardiovascular events in patients with myocardial infarctionSerge Korjian, Syed Hassan A Kazmi, Gerald Chi, et al.
Acta Neuropathologica|August 30, 2017
MSA prions exhibit remarkable stability and resistance to inactivationAmanda L Woerman, Sabeen A Kazmi, Smita Patel, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 9, 2010
Discovery of a CXCR4 agonist pepducin that mobilizes bone marrow hematopoietic cellsBoris Tchernychev, Yong Ren, Pallavi Sachdev, et al.
Chemosphere|January 26, 2023
Resolution of conflict of reduced sludge production with EBPR by coupling OSA to A<sup>2</sup>/O process in a pilot scale SBRAnwar Khursheed, Faris Mohammad A Munshi, Abdulaziz Ibrahim Almohana, et al.
American Journal of Clinical Oncology|July 23, 2020
Feasibility and Outcome of Routine Use of Concurrent Chemoradiation in HIV-positive Patients With Squamous Cell Anal CancerAndrew J Leiker, Chiachien J Wang, Nina N Sanford, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|October 25, 2022
CSL112 (Apolipoprotein A-I [Human]) Strongly Enhances Plasma Apoa-I and Cholesterol Efflux Capacity in Post-Acute Myocardial Infarction Patients: A PK/PD Substudy of the AEGIS-I TrialC Michael Gibson, Syed Hassan A Kazmi, Serge Korjian, et al.
Acta Neuropathologica|January 29, 2019
Multiple system atrophy prions retain strain specificity after serial propagation in two different Tg(SNCA*A53T) mouse linesAmanda L Woerman, Abby Oehler, Sabeen A Kazmi, et al.
Current Cardiology Reports|March 15, 2019
Most Promising Therapies in Interventional CardiologyMathieu Kerneis, Tarek Nafee, Megan K Yee, et al.
Pageof 16

Showing results (131-140 of 156) with videos related to

Sort By:
Pageof 16
The Oncologist|October 24, 2013
Impact of molecular alterations and targeted therapy in appendiceal adenocarcinomasKanwal P S Raghav, Aditya V Shetty, Syed M A Kazmi, et al.
Plos Biology|June 30, 2021
An oxytocin/vasopressin-related neuropeptide modulates social foraging behavior in the clonal raider antIngrid Fetter-Pruneda, Taylor Hart, Yuko Ulrich, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|February 14, 2023
Biological basis and proposed mechanism of action of CSL112 (apolipoprotein A-I [human]) for prevention of major adverse cardiovascular events in patients with myocardial infarctionSerge Korjian, Syed Hassan A Kazmi, Gerald Chi, et al.
Acta Neuropathologica|August 30, 2017
MSA prions exhibit remarkable stability and resistance to inactivationAmanda L Woerman, Sabeen A Kazmi, Smita Patel, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 9, 2010
Discovery of a CXCR4 agonist pepducin that mobilizes bone marrow hematopoietic cellsBoris Tchernychev, Yong Ren, Pallavi Sachdev, et al.
Chemosphere|January 26, 2023
Resolution of conflict of reduced sludge production with EBPR by coupling OSA to A<sup>2</sup>/O process in a pilot scale SBRAnwar Khursheed, Faris Mohammad A Munshi, Abdulaziz Ibrahim Almohana, et al.
American Journal of Clinical Oncology|July 23, 2020
Feasibility and Outcome of Routine Use of Concurrent Chemoradiation in HIV-positive Patients With Squamous Cell Anal CancerAndrew J Leiker, Chiachien J Wang, Nina N Sanford, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|October 25, 2022
CSL112 (Apolipoprotein A-I [Human]) Strongly Enhances Plasma Apoa-I and Cholesterol Efflux Capacity in Post-Acute Myocardial Infarction Patients: A PK/PD Substudy of the AEGIS-I TrialC Michael Gibson, Syed Hassan A Kazmi, Serge Korjian, et al.
Acta Neuropathologica|January 29, 2019
Multiple system atrophy prions retain strain specificity after serial propagation in two different Tg(SNCA*A53T) mouse linesAmanda L Woerman, Abby Oehler, Sabeen A Kazmi, et al.
Current Cardiology Reports|March 15, 2019
Most Promising Therapies in Interventional CardiologyMathieu Kerneis, Tarek Nafee, Megan K Yee, et al.
Pageof 16